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Abstract 
Background:  The identification of key genes and regulatory networks in the transcriptomic 
responses of blood cells to antigen stimulation could facilitate the understanding of host defence 
and disease resistance. Moreover, genetic relationships between immunocompetence and the 
expression of other phenotypes, such as those of metabolic interest, are debated but incompletely 
understood in farm animals. Both positive and negative associations between immune respon-
siveness and performance traits such as weight gain or lean growth have been reported. 
We designed an in vivo microarray study of transcriptional changes in porcine peripheral blood 
mononuclear cells (PBMCs) during the immune response to tetanus toxoid (TT) as a model an-
tigen for combined cellular (Th1) and humoral (Th2) responses. The aim of the study was to in-
vestigate the responsiveness of PBMCs against the background of divergent lean growth (LG) 
performance and anti-TT antibody (AB) titers and to compare lean growth and humoral immune 
performance phenotypes. 
Results: In general, high LG phenotypes had increased cellular immune response transcripts, 
while low AB phenotypes had increased transcripts for canonical pathways that represented 
processes of intracellular and second messenger signaling and immune responses. Comparison of 
lean growth phenotypes in the context of high AB titers revealed higher cellular immune response 
transcripts in high LG phenotypes. Similar comparisons in the context of low AB titers failed to 
identify any corresponding pathways. When high and low AB titer phenotypes were differentially 
compared, low AB phenotypes had higher cellular immune response transcripts on a low LG 
background and higher cell signaling, growth, and proliferation transcripts on a high LG back-
ground. 
Conclusions: Divergent phenotypes of both lean growth performance and humoral immune 
response are affected by significant and functional transcript abundance changes throughout the 
immune response. The selected high-performance phenotypes demonstrated both high AB titers 
and increased transcript abundance of cellular immune response genes, which were possibly offset 
by lower expression of other cellular functions. Further, indications of compensatory effects were 
observed between cellular and humoral immune responses  that became visible only in 
low-performance phenotypes. 
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Introduction 
Animal health and welfare dictates livestock 
quality and the practice of economically efficient 
farming; in turn, animal health relies on the preven-
tion of infectious diseases. Therefore, the genetic 
fundamentals of immunocompetence, or immunoge-
netics, have become a central research subject in farm 
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animals. Moreover, strong selection for production 
traits is presumed to have led to impairments con-
cerning behavior, physiology and immune function 
[1,2]. Hence, comprehensive selection approaches for 
traits of disease resistance and immunocompetence 
are proposed [3-6]. However, the relationship be-
tween performance traits and immunocompetence, 
genetic fundamentals, and impacts on breeding are 
not well understood. Concerning the direct relation-
ship between immune responsiveness  and perfor-
mance, earlier porcine studies report a negative cor-
relation between post-vaccination antibody titers and 
weight gain [7]. Conversely, other studies report that 
selection for high immune response associates with 
enhanced weight gain [8,9].  Clapperton and col-
leagues [10] show that selection for lean growth asso-
ciates with higher numbers of several types of lym-
phocytes and monocytes in Large White pigs. 
Transcriptome profiling of peripheral blood 
mononuclear cells (PBMCs) throughout immune re-
sponses is widely used to identify the extent and ki-
netics of differential gene expression [11-16]. Identi-
fication of affected signaling and metabolic pathways 
and their key genes allows better understanding of 
host defence and disease resistance. Moreover, the 
PBMC transcriptome represents not only the primary 
immune function of leukocytes, but also displays 
transcriptomic shifts of other tissues and organs due 
to physiological and environmental alterations 
[17-19]. Immune-stimulated physiological and meta-
bolic  changes in other tissues may also manifest 
through  PBMC  gene expression, however, this  re-
mains to be confirmed.  
Previously, we evaluated a microarray study of 
in vivo  transcriptional changes in porcine PBMCs 
during the immune response to tetanus toxoid (TT) as 
a model antigen for a combined immune response 
[16]. TT vaccines trigger both the cellular (Th1) and 
humoral (Th2) branches of the immune system [20,21] 
and represent a non-ubiquitous  antigen for which 
weaning piglets are antigen-naïve [11]. To gain fur-
ther insight into the relationship between immuno-
competence and performance, here we compared the 
responsiveness of PBMCs to TT vaccination against 
the background of divergent lean growth perfor-
mance and anti-TT antibody (AB) titers, respectively. 
Analyses of affected canonical pathways and down-
stream effects were compared between divergent 
phenotypes for lean growth performance  and hu-
moral immune response.  
Material and methods 
Animals, vaccination, sampling and phenotype 
recording  
The Leibniz-Institute for Farm Animal Biology 
provided animals and permission for this study. 
Animal care, vaccination, and blood collection were 
performed according to the guidelines of the German 
Law of Animal Protection. The experimental protocol 
was approved by the Animal Care Committee of the 
Leibniz Institute of Farm Animal Biology and the 
State Mecklenburg-Vorpommern (Landesamt für 
Landwirtschaft, Lebensmittelsicherheit und Fischerei; 
LALLF M-V/TSD/7221.3-2.1-020/09). 
The experimental design is outlined in Fig. 1. 
One week after weaning, 160 five-week-old German 
Landrace piglets of a commercial herdbook herd were 
initially vaccinated (day 0) subcutaneously with one 
dose (1 mL) of tetanus vaccine, composed of TT and 
aluminium hydroxide as adjuvant (Equilis Teta-
nus-Vaccine, Intervet, Unterschleißheim, Germany). 
After two weeks, a booster vaccination was given 
(day 14). EDTA blood samples were collected directly 
before the first (day 0) and second vaccination 
(day 14), as well as two weeks after the booster 
(day 28). Plasma samples were prepared and 
stored at -80°C until further analysis. Plasma 
anti-TT AB titers were determined in triplicate 
using a commercially available ELISA 
(RE57441, IBL International, Hamburg, Ger-
many) according to manufacturer's protocol.  
 
Figure 1. Experimental design. Five-week-old piglets were 
vaccinated twice with TT. Directly before the first (day 0) and the 
second (day 14) vaccination as well at day 28 blood samples were 
collected and PBMCs were isolated. Anti-TT antibody titers were 
quantified by ELISA from day 28 plasma samples. Animals were 
then performance-tested. Performance data and AB titers were 
interpreted as a basis for the identification of divergent pheno-
types of lean growth performance and humoral immune re-
sponse, respectively. Finally, expression profiles of divergent 
phenotypes for lean growth and humoral immune performance 
were compared. Int. J. Biol. Sci. 2013, Vol. 9 
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Juvenile animals (average age of 10 weeks) were 
performance tested and evaluated during fattening 
and at slaughter (final average weight of 110 kg). 
Performance test data were subjected to a principal 
component analysis, which identified the first com-
ponent (factor 1) explaining 39% of the total variance 
(Supplementary  Table 1). Among the animals there 
was no evidence for association between performance 
and immune traits. In fact, coefficients of correlation 
between performance traits and plasma anti-TT AB 
titers were low (r ≤ 0.1), thus facilitating the selection 
of animals that represent divergent groups for both 
traits.  Key parameters (loads) of factor 1 (Table 1) 
were taken as a basis for the identification of lean 
growth performance phenotypes. For final phenotype 
rating, animals from the respective terciles of highest 
and lowest factor 1 values were categorized as high 
(hiLG) and low (loLG) lean growth performance, re-
spectively. Accordingly, animals assigned to the first 
and the third terciles of TT-AB titers were rated as 
high (hiAB) and low humoral immune response (lo-
AB) phenotypes, respectively.  
Finally,  ten  animals  each  were selected being 
representatives of one of the two terciles for lean 
growth performance and of one of the two terciles for 
antibody response, respectively. The four groups that 
were set up for subsequent analyses were balanced 
for sex and litter.  
 
Table 1. Key traits used for phenotype rating of high lean growth 
and low lean growth performance. 
Trait  High lean 
growth 
  Low lean 
growth 
  High vs. 
low 
Mean  SD     Mean  SD    p-value 
Average backfat (cm)  1.86  0.21    2.44  0.3
5 
  5.93 x E-07 
Fat area (cm2)  14.9  2.8    21.5  3.8    3.66E-07 
Loin eye area (cm2)  53.0  4.4    48.0  6.2    6.34E-03 
Meat to fat ratio  3.7  0.9    2.3  0.6    1.55E-06 
Lean mean content (%)  59.9  1.9    54.6  3.7    4.75E-06 
 
RNA preparation and microarray hybridiza-
tion 
PBMCs were isolated from 4-mL blood samples 
by centrifugation on a Histopaque density gradient 
(Sigma-Aldrich, Taufkirchen, Germany). PBMC 
preparations were stored at -80°C. Total RNA was 
isolated using Qiazol reagent (Qiagen, Hilden, Ger-
many), then treated with DNase and column-purified 
using the RNeasy Mini Kit (Qiagen). RNA integrity 
was visualized by separation on a 1% agarose gel 
containing ethidium bromide and the concentration 
was quantified by a NanoDrop ND-1000 spectrometer 
(PEQLAB, Erlangen, Germany). DNA contamination 
was assessed by PCR amplification of the porcine 
GAPDH gene (forward primer: 5’-AAGCAGG 
GATGATGTTCTGG-3’; reverse primer: 
5’-ATGCCTCCTGTACCACCAAC-3’). All RNA was 
stored at -80°C. 
Each RNA sample was transcribed to DNA us-
ing the Ambion WT Expression Kit (Ambion, Austin, 
TX, USA). DNA preparations were fragmented and 
labelled with the WT Terminal Labeling Kit (Affy-
metrix, Santa Clara, CA, USA). Labelled DNA was 
hybridized on snowball arrays, a recently developed 
and annotated whole genome array [22,23]. Further 
information about this platform is also available in the 
‘ArrayExpress’ database  (accession number 
A-AFFY-189,  http://www.ebi.ac.uk/arrayexpress/ 
arrays/A-AFFY-189/). Following staining and wash-
ing, arrays were scanned and raw data generated us-
ing Affymetrix GCOS 1.1.1 software. Microarray data 
is MIAME-compliant and was deposited in the data-
base of the National Center for Biotechnology Infor-
mation Gene Expression Omnibus http://www.ncbi. 
nlm.nih.gov/geo [GEO: GSE47845]. 
Microarray data processing and functional 
analyses 
Quality-controlled raw data were normalized by 
the PLIER algorithm using Affymetrix Expression 
Console 1.1 software (Affymetrix) and filtered by 
standard deviation (s ≤ 0.2). According to the experi-
mental design aiming at showing contrasts of the 
PBMC transcription due to antibody responsiveness 
and lean growth performance of the test subjects the 
factor of immune response group (`IR´) and lean 
growth performance group (`P´) were used as fixed 
effects in the analysis of variance. Since the genetic 
background and the age at sampling and expression 
profiling affect the gene activity `sire´ (`S´) and `time´ 
(`T´) were also fitted as fixed effects in a mixed model. 
So essentially, relative transcript abundance changes 
were determined using these fixed effects and the 
interactions between `IR´ and `P´ and between `T´, 
`IR´, and `P´ [v = μ + S + T + IR + P + (IR x P) + (T x IR 
x P) + ε]. The mixed model was combined with a re-
peated statement for the time component in order to 
take into account correlations among measurements 
made on the same subject by specifying heterogene-
ous covariance structure.  
Thus  sampling  time points were weighted 
equally  while comparing lean growth and humoral 
immune response phenotypes. Mixed model analyses 
were performed with JMP Genomics 5.0 software 
(SAS Institute, Cary, NC, USA). 
Annotation data for the snowball arrays were 
obtained from the developers [22,23]. Transcripts Int. J. Biol. Sci. 2013, Vol. 9 
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showing different abundance at nominal p-values < 
0.5 were assigned to annotated genes and bioinfor-
matically analysed with Ingenuity Pathways Analysis 
(IPA) Software [24]. At the levels of IPA’s functional 
analyses for canonical pathways and biofunctions a 
correction for multiple testing was applied by use of 
IPA's B-H p-value correction procedure. Cut-off crite-
ria were set to corrected p-values < 0.05 for canonical 
pathways and for biofunctions, respectively, and ab-
solute values of activation z-scores > 2.0 for biofunc-
tions. 
Results 
Antibody titer and performance characteriza-
tion 
In order to analyse different transcript abun-
dance of PBMC due to immune responsiveness and 
lean growth performance five-week-old German 
Landrace piglets were initially vaccinated (day 0) with 
TT, and a booster vaccination was given on day 14. 
Animals were then performance-tested until a final 
average weight of 110 kg at slaughter. Animals of the 
tails of the distribution for the trait AB titer against TT 
and lean growth performance were selected. Plasma 
anti-TT AB titers, determined by enzyme-linked im-
munosorbent assay (ELISA) at two weeks after 
booster vaccination, ranged from <0.1 IU/mL to >1.0 
IU/mL (mean = 0.33 IU/mL; standard deviation = 
0.23 IU/mL). AB titers were interpreted as a basis for 
the identification of divergent phenotypes of high 
humoral immune response (hiAB) and low humoral 
immune response (loAB) and differed significantly 
among  both groups (hiAB: mean = 0.57 IU/mL; 
standard deviation = 0.13 IU/mL; loAB: mean = 0.23 
IU/mL; standard deviation = 0.04 IU/mL; p < 0.001). 
Lean growth performance phenotypes were obtained 
by the first component of a principal component 
analysis  of extensive performance data. Highly sig-
nificant differences for key parameters of this first 
component were used for phenotype rating of high 
lean growth (hiLG) and low lean growth (loLG) per-
formance (Table 1). 
Differentially-expressed genes and assigned 
functions for divergent lean growth perfor-
mance phenotypes 
Using Ingenuity Pathways Analysis (IPA) soft-
ware [24], genes with significantly different transcript 
abundances (hereafter referred to as DE-genes) were 
assigned to affected canonical pathways and altered 
downstream effects (hereafter referred to as biofunc-
tions).  
Comparison of hiLG and loLG  revealed 574 
DE-genes (Table 2) that were assigned to pathways 
predominated by the cellular immune response (Table 
4a). The most significant pathways, including T-cell 
receptor, PKCθ, and CD28 signaling, are responsible 
for co-stimulation during lymphocyte activation and 
showed higher transcript abundances in the hiLG 
group. Functional analysis predicted decreased or-
ganismal death and increased development, differen-
tiation, and homeostasis of lymphocytes for the hiLG 
phenotype (Table 5a). 
DE-genes and assigned functions for divergent 
humoral immune response phenotypes 
Comparison of hiAB and loAB revealed 522 
DE-genes (Table 2). The loAB group showed higher 
transcript abundances for canonical pathways (Table 
4b) that represented processes of intracellular and 
second messenger signaling (integrin signaling, 
phospholipase C signaling) and immune responses 
(clathrin-mediated endocytosis signaling, IL-8 sig-
naling). Functional analyses predicted decreased cell 
adhesion, aggregation, proliferation, and differentia-
tion in hiAB phenotypes (Table 5b). 
Differentiated comparisons between divergent 
lean growth performance and humoral im-
mune response phenotypes 
The identification of hiLG, loLG, hiAB, and loAB 
phenotypes enabled differentiated comparisons be-
tween hiLG and loLG against backgrounds of hiAB 
and loAB, respectively, and vice versa: hiLG+hiAB vs. 
loLG+hiAB;  hiLG+loAB  vs.  loLG+loAB;  hiLG+hiAB 
vs. hiLG+loAB; and loLG+hiAB vs. loLG+loAB (Fig. 
1). Each comparison revealed more than 400 DE-genes 
(Table 3).  
Similar to the comparison between hiLG and 
loLG, the hiLG+hiAB vs. loLG+hiAB comparison re-
vealed higher transcript abundances in the 
hiLG+hiAB  phenotype  that  affected  pathways  as-
signed exclusively to cellular immune responses (Fig. 
2). Correspondingly, downstream effects analysis 
predicted activation of lymphocyte development, 
differentiation, and homeostasis and decreased leu-
kocyte apoptosis in hiLG+hiAB (Fig. 3). Although the 
hiLG+loAB  vs.  loLG+loAB  comparison represented 
441 DE-genes, no corresponding pathway or biofunc-
tion was identified. 
When high and low AB titer phenotypes were 
differentially compared, higher trancript abundances 
were  found  for  loLG+loAB  compared  to  the 
loLG+hiAB  phenotype.  These  DE-genes were as-
signed to canonical pathways of the cellular immune 
response (Fig. 2) and to an increase of biofunctions 
such as activation and differentiation of lymphocytes, 
particularly T lymphocytes, and differentiation of 
helper T cells (Fig. 3). Int. J. Biol. Sci. 2013, Vol. 9 
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The comparison of divergent AB titer pheno-
types  with high lean growth,  hiLG+hiAB  vs. 
hiLG+loAB,  revealed pathways with cell signaling, 
growth, and proliferation functions, rather than dis-
tinct  immune  responses (Fig. 2).  Transcript abun-
dances  were  higher  in  the  hiLG+loAB  group  and 
predicted activation of cell transformation and 
spreading, survival, aggregation, adhesion, and 
binding (Fig. 3). 
 
Table 2. Numbers of differentially-expressed (DE-) genes from comparison of lean growth performance and antibody titers 
  Main phenotype comparisons  
Lean growth performance:  
high vs. low 
Antibody titer: 
high vs. low 
Number of DE-genes  574  522 
Transcript Abundance >  366  133 
Transcript Abundance <  208  389 
 
Table 3. Numbers of DE-genes from differentiated comparisons between lean growth performance and antibody titers 
  Differentiated comparisons for high (hi) and low (lo) lean growth (LG) and antibody (AB) phenotypes 
hiLG+hiAB vs. loLG+hiAB  hiLG+hiAB vs. hiLG+loAB   loLG+hiAB vs. loLG+loAB  hiLG+loAB vs. loLG+loAB 
Number of DE-genes  432  407  489  441 
Transcript Abundance >  311  111  129  293 
Transcript Abundance <  121  296  360  148 
 
Table 4. Top 10 canonical pathways for lean growth performance (a) and antibody titer (b) phenotype comparisons 
Canonical Pathway  Pathway category  -log p-value  Genes 
involved 
Transcript abundance 
>  < 
 (a) Lean growth performance: high vs. low       
T Cell Receptor Signaling  1  3.84  13  12  1 
PKCθ Signaling in T Lymphocytes  1  3.84  14  11  3 
CD28 Signaling in T Helper Cells  1  3.84  14  10  4 
CTLA4 Signaling in Cytotoxic T Lymphocytes  1  3.75  12  10  2 
Role of NFAT in Regulation of the IR  1,2,3  3.42  16  11  5 
Phospholipase C Signaling  3  3.42  19  13  6 
iCOS-iCOSL Signaling in T Helper Cells  1  3.16  12  8  4 
Protein Kinase A Signaling  3  3.16  25  14  11 
Calcium-induced T Lymphocyte Apoptosis  4,1  2.99  9  7  2 
CCR5 Signaling in Macrophages  1,5  2.63  9  7  2 
(b) Antibody titer: high vs. low 
Integrin Signaling  3,6,7  8.08  24  1  23 
Phospholipase C Signaling  3  4.86  21  4  17 
Clathrin-mediated Endocytosis Signaling  1,8,9  4.70  18  1  17 
IL-8 Signaling  1,5  4.70  18  3  15 
Thrombin Signaling  10  4.56  18  2  16 
Role of NFAT in Regulation of the IR  1,2,3  4.56  17  3  14 
PTEN Signaling  4  4.56  14  0  14 
P2Y Purigenic Receptor Signaling Pathway  10  4.26  14  2  12 
Ephrin Receptor Signaling  9  4.01  16  2  14 
CXCR4 Signaling  1,5  3.94  15  1  14 
Pathway categories: 
1 Cellular immune response;        2 Humoral immune response; 
3 Intracellular and second messenger signalling;    4 Apoptosis; 
5 Cytokine signalling;          6 Cellular growth, proliferation and development; 
7 Cell cycle regulation;          8 Pathogen-influenced signaling; 
9 Organismal growth and development;      10 Cardiovascular signaling; 
Abbreviation: IR Immune response Int. J. Biol. Sci. 2013, Vol. 9 
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Table 5. Top 15 biofunctions for lean growth performance (a) and antibody titer (b) phenotype comparisons 
  Activation    # Genes  Predicted 
Annotated functions  z-score  -log p-value  involved  activation state 
(a) Lean growth performance: high vs. low     
organismal death  -4.39  2.90  77  < 
development of leukocytes  3.51  4.29  39  > 
differentiation of lymphocytes  3.38  6.46  40  > 
cellular homeostasis  3.35  5.15  74  > 
lymphocyte homeostasis  3.31  4.14  36  > 
T cell development  3.28  4.04  34  > 
development of blood cells  3.25  3.94  41  > 
development of lymphocytes  3.23  4.18  37  > 
T cell homeostasis  3.18  4.19  35  > 
development of cardiovascular system  3.04  3.79  56  > 
differentiation of mononuclear leucocytes  2.97  6.46  42  > 
development of blood vessel  2.94  2.59  42  > 
differentiation of B lymphocytes  2.78  3.48  19  > 
differentiation of leucocytes  2.70  6.25  47  > 
quantity of helper T lymphocytes  2.59  2.54  15  > 
         
(b) Antibody titer: high vs. low 
adhesion of blood cells  -4.01  1.75  22  < 
aggregation of cells  -3.92  3.68  24  < 
aggregation of blood cells  -3.58  3.97  21  < 
aggregation of blood platelets  -3.32  4.60  142  < 
proliferation of cells  -2.99  5.52  83  < 
differentiation of cells  -2.96  3.03  25  < 
cell transformation  -2.79  1.89  34  < 
differentiation of blood cells  -2.78  1.49  43  < 
activation of cells  -2.61  1.64  98  < 
cell movement  -2.48  7.32  23  < 
hemostasis  -2.47  5.77  39  < 
activation of blood cells  -2.38  2.37  89  < 
migration of cells  -2.37  6.50  34  < 
proliferation of T lymphocytes  -2.36  2.52  55  < 
cellular homeostasis  -2.31  1.56  35  < 
 
 
 
 
 
Figure 2.  Affected canonical 
pathways revealed by differen-
tiated comparisons of four 
phenotypic groups. Symbols  > 
and < refer to overall transcript 
abundance and were set if more 
than 75 % of involved DE-genes 
showed positive or negative fold 
change, respectively. Int. J. Biol. Sci. 2013, Vol. 9 
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Figure 3. Altered biofunctions revealed by differentiated comparison between four phenotypic groups. Symbols > and < refer to IPA prediction of 
increased (>) or decreased (<) activation state of the respective biofunction. 
 
Discussion 
In animal farming, the relationship between 
performance traits and immunocompetence, its ge-
netic foundation, and the consequences for animal 
breeding are debated but poorly understood. Previ-
ous work addressed the physiological costs of im-
mune responses leading to disease resistance [25]. In 
addition, there are numerous reports about how cer-
tain factors like pathogen infection, poor hygiene 
conditions or physical and psychological stressors led 
to a metabolic impairment and thus to lower perfor-
mance [25]. The resource allocation theory postulates 
the existence of metabolic constraints between im-
mune  function and growth performance [26,27]. 
However, immune activation and resulting metabolic 
impairments should be differentiated from genetically 
determined differences in immune responsiveness 
and performance potential in terms of weight gain, 
lean growth, and other production traits. Knap and 
Bishop [28] review evidence of genetic variation and 
discuss several breeding approaches to improve the 
genetic potential for immunocompetence.  
Porcine selection for high immune response was 
found associated with enhanced weight gain [8,9], 
whereas selection for lean growth was observed as-
sociated with higher numbers of several leukocyte 
subtypes  [10]. In addition, Galina-Pantoja  et al.  [29] 
provide evidence for the association of several leu-
kocyte subsets with growth traits. However, inverse 
correlations between antibody titers after vaccination 
and weight gain [7] and between PBMC subsets and 
daily weight gain have also been reported [30,31]. 
These results suggest an incomplete understanding of 
the correlation between immunocompetence and 
performance traits.  
In  pigs  undifferentiated by phenotype,  we  ob-
served  a broad transcriptomic response to TT that 
comprises changes to the abundance of immune re-
sponse, cellular growth, proliferation,  development, 
intracellular  messenger,  and second messenger sig-
naling transcripts [16]; therefore, we asked whether 
phenotype differentiation would affect these re-
sponses. The results presented here reveal differen-
tially-modulated transcriptomic responses of immune 
pathways and broad processes of cellular reorganiza-
tion with respect to the phenotypic differences in lean 
growth performance and antibody response. Int. J. Biol. Sci. 2013, Vol. 9 
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hiLG  transcripts were increased for  canonical 
pathways  related to  cellular  immune response and 
biofunctions  predicted to increase lymphocyte  dif-
ferentiation,  development, and homeostasis,  but  to 
decrease  leukocyte  apoptosis, compared to loLG 
transcripts.  These  findings  are concurrent with the 
more  differentiated comparison of  hiLG+hiAB  vs. 
loLG+hiAB.  
Although the comparison of  hiLG+loAB  vs. 
loLG+loAB  revealed 441 DE-genes, similar to  the 
other  differentiated comparisons, no significant 
pathway or affected biofunction  was  identified. 
Hence, the background of low humoral immune re-
sponsiveness provided no clear functional differences 
for divergent lean growth. 
Among the most significant canonical pathways, 
several were related to T-cell activities. For example, T 
cell receptor (TCR) signaling is initiated after major 
histocompatibility complex-associated antigens are 
recognized and bound by the TCR-CD3 complex. 
Transcript abundances of CD3 and the co-stimulatory 
receptor CD8 increased  in  hiLG  and  hiLG+hiAB 
compared to loLG groups. In TCR signaling, antigen 
binding to TCR leads to an initial sequence of tyrosi-
nase activity followed by further downstream sig-
naling,  which leads  to transcriptional activation of 
several genes including IL-2, a key-cytokine of Th1 
response.  Moreover,  we found elevated transcript 
abundance of c-FOS  encoding a component of the 
transcription factor AP1 that activates cytokine and 
other immune effector genes.  Higher  abundance  of 
CD8 transcripts in hiLG may indicate higher numbers 
of cytotoxic T lymphocytes (CTLs) or a higher rate of 
differentiation into CTLs. In addition to TCR signal-
ing, the following pathways are closely related: PKCθ 
signaling  in T lymphocytes; CD28 signaling in T 
helper cells; CTLA4 signaling in cytotoxic T lympho-
cytes; and NFAT regulation of the immune response. 
These signal transduction mechanisms are initiated by 
antigen recognition by TCR-CD3 and co-stimulation 
of CD28 to activate and differentiate T cells, which 
involve  cell survival,  proliferation, and the produc-
tion of IL-2. The enrichment of these pathway genes 
indicates the predominance of cell-mediated immune 
responses. Thus, the high lean growth phenotype in 
our study was characterized by several favourable 
performance traits and a transcriptomic response in-
dicative for high cellular immunocompetence, partly 
combined with a strong humoral defense. 
hiAB and loAB comparison revealed the hiAB 
group had a lower abundance of transcripts related to 
canonical cellular biology pathways (integrin and 
phospholipase C signaling) and immune responses 
(clathrin-mediated endocytosis and IL-8 signaling). 
Functional analysis demonstrated cell adhesion, ag-
gregation, proliferation, and differentiation among 
the predominant processes. However, depending on 
backgrounds of hiLG and loLG, respectively, the dif-
ferentiated comparisons show differently affected 
functions (Fig. 3). This indicates that affected path-
ways with primary immune functions did not neces-
sarily reflect TT AB titers. Similar observations that 
immune assays may not reflect immunocompetence 
were reported [32]. However, it should be taken into 
account that the lymphocyte fraction of peripheral 
blood is composed of a smaller fraction of B lympho-
cytes compared to T cells, which may impair to some 
extent the detection of shifted transcript abundances 
in  B  cells.  The  comparison  of  loLG+hiAB  vs. 
loLG+loAB  presented  pathways  responsible  for 
cell-mediated immune responses and biofunctions 
predominated by differentiation and activation of 
lymphocytes. Since loAB phenotypes showed exclu-
sively higher transcript abundances for cellular im-
mune responses, compensatory effects between hu-
moral and cellular immune responses visible only for 
low performance phenotypes may be present. 
Against the background of hiLG (hiLG+hiAB vs. 
hiLG+loAB),  no  transcript abundance alterations 
were found for primary immune pathways. However, 
cellular and organismal growth, proliferation and 
development (integrin,  ephrin  receptor,  and  gap 
junction  signaling),  and intracellular and second 
messenger  signaling  (integrin,  rhoGDI  signaling) 
pathways were affected. Decreased transcript abun-
dances  in  hiLG+hiAB  compared  to  hiLG+loAB  had 
predicted biofunctions in cell transformation, aggre-
gation, binding, and survival. Given that hiLG+hiAB 
phenotypes possessed both high AB titers and strong 
transcriptional  immune responses,  the increased 
T-cell activation transcripts were possibly offset by 
lower expression of several cell signaling  and reor-
ganization  functions. It remains to be examined 
whether lower expression of other functions impair 
physiological or metabolic functions. 
AB divergent phenotype comparisons revealed 
integrin signaling as the most significant pathway. 
Integrin DE-genes  ITGA2, ITGA2B,  and  ITGB3  in-
creased 1.2-  to 1.4-fold in loAB compared to hiAB; 
transcripts increased 1.4-  to 1.6-fold  in  hiLG+loAB 
compared  to  hiLG+hiAB  (Supplementary  Table 2). 
Integrins are transmembrane molecules that enable 
attachment to and communication with other cells or 
the extracellular matrix. Although the IPA database 
does not attribute integrin signaling to the immune 
system, integrins may play a crucial role in the leu-
kocyte immune response. Hogg and colleagues [33] 
showed that integrin-mediated leukocyte migration 
through the body and into lymph nodes is essential 
for immune responses. Moreover, integrins are in-Int. J. Biol. Sci. 2013, Vol. 9 
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volved in the interaction between T cells and anti-
gen-presenting cells  by both synaptic adhesion and 
direct signaling [34].  
Balanced immunocompetence without polarity 
of either cellular-mediated (Th1) or humoral (Th2) 
immune responses is a proposed selection goal to 
avoid resistance to specific infections/diseases or in-
creased susceptibility to others [3]. Thus, a balanced 
Th1/Th2 phenotype, rather than extreme Th1 or Th2 
responders, is desired for general disease resistance 
[35]. Because cytokine production and Th1/Th2 ratios 
are highly variable within a pig population [35-37], 
one can assume that the prevalence of either Th1 or 
Th2 responses is genetically fixed. Our observations 
of considerable  transcriptomic  differences between 
humoral  and cellular-mediated immune responses 
corroborate these results. One might speculate that 
loAB individuals activate a higher cellular immune 
response to compensate for lower antibody-mediated 
immunity. Immune tolerance is an alternative host 
strategy to deal with pathogens [38] that is discussed 
for possible integration in selective pig breeding 
[39-41]. 
Recent research reported further insight into the 
relationship between obesity and adipose tissue in-
flammation [42]. Increased numbers of macrophages 
and T cells and their production of pro-inflammatory 
cytokines cause obesity-associated insulin resistance 
in several tissue types [43,44]. Association of adiposity 
with metabolic impairments and a low-grade in-
flammatory state was also shown in pig [45]. Assum-
ing  a higher susceptibility for insulin resistance in 
obese animals from our experimental population, the 
immune status of low performance animals may dif-
fer from that of lean growth animals. Further, if adi-
pose tissue can contribute to disease resistance or host 
tolerance through the systemic immune system, the 
relationship between fat and immunocompetence 
becomes more complex. These factors will have to be 
considered for the integration of genetics and pheno-
type expression into breeding programs. 
Conclusions 
We observed significant functional transcript 
abundance changes during the immune response to 
TT for both divergent lean growth performance and 
humoral immune responses. High lean growth 
showed activated cellular immune responses related 
to lymphocyte differentiation, development, and ho-
meostasis compared to low lean growth phenotypes. 
Increased transcript abundances for immune activa-
tion were possibly offset by decreased expression of 
several cell signaling and reorganization functions; 
however, numerous favourable performance traits 
suggest a lack of physiological or metabolic impair-
ment. The majority of affected primary immune 
pathways did not reflect AB titer differences. Partic-
ularly, in low lean growth performers low humoral 
immune responders revealed higher transcriptional 
activation of cellular immune responses than low AB 
responders, suggesting compensatory effects between 
humoral and cellular immune responses. However, 
the group of the most desired animals with high lean 
growth and high humoral immune response 
(hiLG+hiAB) revealed also higher transcriptional ac-
tivation of cellular immune responses compared to 
the low performing group. Though the 
above-mentioned compensatory effects may exist, this 
finding demonstrates the occurrence of individuals 
with superior performance combined with high Th1 
and Th2 immune responsiveness. 
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